Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a research report released on Sunday. The brokerage issued a hold rating on the stock.

Retractable Technologies Trading Down 3.0 %

Shares of RVP opened at $0.80 on Friday. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. Retractable Technologies has a 1-year low of $0.56 and a 1-year high of $1.33. The company has a market capitalization of $23.80 million, a P/E ratio of -1.47 and a beta of 1.96. The firm’s 50 day simple moving average is $0.76 and its 200 day simple moving average is $0.77.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Wealthfront Advisers LLC bought a new position in Retractable Technologies in the fourth quarter valued at $1,748,000. Renaissance Technologies LLC boosted its holdings in shares of Retractable Technologies by 9.4% in the 4th quarter. Renaissance Technologies LLC now owns 361,253 shares of the company’s stock worth $249,000 after purchasing an additional 31,140 shares in the last quarter. Finally, PFG Investments LLC bought a new position in shares of Retractable Technologies during the 3rd quarter valued at about $27,000. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Read More

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.